BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17425606)

  • 1. The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells.
    Falluel-Morel A; Chafai M; Vaudry D; Basille M; Cazillis M; Aubert N; Louiset E; de Jouffrey S; Le Bigot JF; Fournier A; Gressens P; Rostène W; Vaudry H; Gonzalez BJ
    J Neuroendocrinol; 2007 May; 19(5):321-7. PubMed ID: 17425606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cerebellar development in mice lacking pituitary adenylate cyclase-activating polypeptide.
    Allais A; Burel D; Isaac ER; Gray SL; Basille M; Ravni A; Sherwood NM; Vaudry H; Gonzalez BJ
    Eur J Neurosci; 2007 May; 25(9):2604-18. PubMed ID: 17561835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32.
    Vaudry D; Gonzalez BJ; Basille M; Pamantung TF; Fontaine M; Fournier A; Vaudry H
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13390-5. PubMed ID: 11087878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis.
    Vaudry D; Cottet-Rousselle C; Basille M; Falluel-Morel A; Fournier A; Vaudry H; Gonzalez BJ
    Regul Pept; 2004 Dec; 123(1-3):43-9. PubMed ID: 15518892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death.
    Vaudry D; Rousselle C; Basille M; Falluel-Morel A; Pamantung TF; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6398-403. PubMed ID: 11972030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide promote the genesis of calcium currents in differentiating mouse embryonic stem cells.
    Chafai M; Basille M; Galas L; Rostene W; Gressens P; Vaudry H; Gonzalez BJ; Louiset E
    Neuroscience; 2011 Dec; 199():103-15. PubMed ID: 22001490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathway.
    McIlvain HB; Baudy A; Sullivan K; Liu D; Pong K; Fennell M; Dunlop J
    Brain Res; 2006 Mar; 1077(1):16-23. PubMed ID: 16487495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells.
    Vaudry D; Falluel-Morel A; Basille M; Pamantung TF; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ
    J Neurosci Res; 2003 May; 72(3):303-16. PubMed ID: 12692897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization.
    Allais A; Burel D; Roy V; Arthaud S; Galas L; Isaac ER; Desfeux A; Parent B; Fournier A; Chapillon P; Sherwood NM; Vaudry H; Gonzalez BJ
    J Neurochem; 2010 Apr; 113(2):329-40. PubMed ID: 20050979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropeptide pituitary adenylate cyclase activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway.
    El Zein N; Badran BM; Sariban E
    Cell Signal; 2007 Jan; 19(1):152-62. PubMed ID: 16914291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
    Aubert N; Basille M; Falluel-Morel A; Vaudry D; Bucharles C; Jolivel V; Fisch C; De Jouffrey S; Le Bigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Comp Neurol; 2007 Oct; 504(4):427-39. PubMed ID: 17663433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of PACAP receptors in the human cerebellum: perspectives of therapeutic applications.
    Basille M; Falluel-Morel A; Vaudry D; Aubert N; Fournier A; Fréger P; Gallo-Payet N; Vaudry H; Gonzalez B
    Regul Pept; 2006 Nov; 137(1-2):27-33. PubMed ID: 16963135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic effects of PACAP in the cerebellar cortex.
    Botia B; Basille M; Allais A; Raoult E; Falluel-Morel A; Galas L; Jolivel V; Wurtz O; Komuro H; Fournier A; Vaudry H; Burel D; Gonzalez BJ; Vaudry D
    Peptides; 2007 Sep; 28(9):1746-52. PubMed ID: 17544170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
    Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
    J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PACAP promotes sensory neuron differentiation: blockade by neurotrophic factors.
    Nielsen KM; Chaverra M; Hapner SJ; Nelson BR; Todd V; Zigmond RE; Lefcort F
    Mol Cell Neurosci; 2004 Apr; 25(4):629-41. PubMed ID: 15080892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.
    Raoult E; Roussel BD; Bénard M; Lefebvre T; Ravni A; Ali C; Vivien D; Komuro H; Fournier A; Vaudry H; Vaudry D; Galas L
    J Neurochem; 2011 Dec; 119(5):920-31. PubMed ID: 21919910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of mRNAs for PACAP and its receptors during neural differentiation of embryonic stem cells.
    Hirose M; Hashimoto H; Shintani N; Nakanishi M; Arakawa N; Iga J; Niwa H; Miyazaki J; Baba A
    Regul Pept; 2005 Mar; 126(1-2):109-13. PubMed ID: 15620423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin and pituitary adenylate cyclase-activating polypeptide (PACAP): two neuropeptides potentially involved in the development of the rat cerebellum.
    Gonzalez BJ; Leroux P; Basille M; Bodenant C; Vaudry H
    Ann Endocrinol (Paris); 1994; 55(6):243-7. PubMed ID: 7864580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development.
    Watanabe J; Nakamachi T; Matsuno R; Hayashi D; Nakamura M; Kikuyama S; Nakajo S; Shioda S
    Peptides; 2007 Sep; 28(9):1713-9. PubMed ID: 17719696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.